WallStreetZenWallStreetZen

NASDAQ: PSTV
Plus Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Plus Therapeutics earnings were -$22.4M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest PSTV earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$5.7M, up 29.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PSTV reported annual earnings of -$22.4M, with 72.5% growth.

PSTV earnings history

Current Revenue
$5.2M
Current Earnings
-$22.4M
Current Profit Margin
-429.4%

PSTV Return on Equity

Current Company
N/A
Current Industry
-30.7%
Current Market
28.9%

PSTV Return on Assets

Current Company
-156%
Current Industry
-9.3%
PSTV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PSTV announces earnings.

PSTV Return on Capital Employed

Current Company
-468.14%
Current Industry
-3.3%
PSTV's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PSTV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PSTV-$18.33M-$22.39MN/A-$0.29
LONA-$36.49M-$37.72MN/A-$9.68
HYPD-$43.45M-$47.00MN/A-$9.40
LITS-$39.70M-$39.70MN/A-$1.73
NBY-$22.00M-$22.14MN/A-$3.80
View Top Biotech Stocks

Plus Therapeutics Earnings Reports & History FAQ

What were Plus Therapeutics's earnings last quarter?

Plus Therapeutics (NASDAQ: PSTV) reported Q4 2025 earnings per share (EPS) of $0.00, up 100% year over year. Total PSTV earnings for the quarter were -$5.71 million. In the same quarter last year, Plus Therapeutics's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Plus Therapeutics stock.

Is Plus Therapeutics profitable or losing money?

As of the last Plus Therapeutics earnings report, Plus Therapeutics is currently losing money. Plus Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$22.39 million, a 72.49% increase year over year.

What was PSTV's earnings growth in the past year?

As of Plus Therapeutics's earnings date in Q1 2026, Plus Therapeutics's earnings has grown year over year. PSTV earnings in the past year totalled -$22.39 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.